MEF2C and epilepsy: Besides, LncRNAUCA1 (long-chain non-coding RNA urothelial carcinoma associated 1) inhibits inflammatory responses to epilepsy by modulating miR203-mediated regulation of the MEF2C/NF-κB signaling pathway, therefore, it may be a potential therapeutic target for epilepsy [80].